Proposed IND Finished Product Specifications. The proposed IND tests, acceptance criteria and justification for the investigational drug, product RUT100-05 are listed in Table 6.6.1. Table 6.6.1 Proposed IND Test and Specifications Test Specification Justification [ ]* [ ]* [ ]* [ ]* [ ]* [ ]* [ ]* [ ]* [ ]* [ ]* [ ]* [ ]* [ ]* [ ]* [ ]* [ ]* [ ]* [ ]* [ ]* [ ]* [ ]* [ ]* [ ]* [ ]* [ ]* [ ]* [ ]* [ ]* [ ]* [ ]* * Confidential material redacted and separately filed with the Commission. 44 Table 6.6.1 Proposed IND Test and Specifications [ ]* [ ]* [ ]* [ ]* [ ]* [ ]*
Appears in 2 contracts
Samples: License and Supply Agreement (Oculus Innovative Sciences, Inc.), License and Supply Agreement (Oculus Innovative Sciences, Inc.)
Proposed IND Finished Product Specifications. The proposed IND tests, acceptance criteria and justification for the investigational drug, product RUT100-05 are listed in Table 6.6.1. Table 6.6.1 Proposed IND Test and Specifications Test Specification Justification [ ]* [ ]* [ ]* [ ]* [ ]* [ ]* [ ]* [ ]* [ ]* [ ]* [ ]* [ ]* [ ]* [ ]* [ ]* [ ]* [ ]* [ ]* [ ]* [ ]* [ ]* [ ]* [ ]* [ ]* [ ]* [ ]* [ ]* [ ]* [ ]* [ ]* * Confidential material redacted and separately filed with Portions of this exhibit, indicated by the Commission. 44 Table 6.6.1 Proposed IND Test and Specifications [ ]* [ ]* [ ]* [ ]* [ ]* xxxx β[ ]*,β were omitted and have been filed separately with the Securities and Exchange Commission pursuant to an application requesting confidential treatment.
Appears in 2 contracts
Samples: License and Supply Agreement (Ruthigen, Inc.), License and Supply Agreement (Ruthigen, Inc.)